Month: August 2008

Health Discovery Corporation has announced that their new gene-based molecular diagnostic test for prostate cancer has now successfully completed its Phase III double-blind clinical trial and is now ready for commercialization. It will be presented at the upcoming Biomarker Discovery Europe 2008 conference in Dublin, Ireland on October 2-3.

Prostate cancer diagnosis tends to be delayed and surgical treatment more difficult in obese men than in lean men, according to two recently published studies.